2023 Annual Awards Gala
Celebrating achievements, advancements, & innovations in women’s health.
SWHR Hosted the 33rd Annual Awards Gala, April 26
Thank you to all the supporters of the Society for Women’s Health Research (SWHR) who gathered in-person, together for SWHR’s 2023 Annual Awards Gala on Wednesday, April 26, 2023 to honor leaders who have significantly advanced women’s health throughout their careers.
This event honored leadership at the U.S. Food and Drug Administration (FDA), Horizon Therapeutics, and University of Illinois Chicago Center for Research on Women and Gender, and featured a keynote speech from the Foundation for the National Institutes of Health (NIH).
The event was held at the InterContinental Washington DC – The Wharf, with the cocktail reception at 6:00 p.m, followed by the dinner and program at 7:00 p.m.
Explore past Galas including the 2022 Annual Awards Gala here.
2023 Award Winners
Kaveeta P. Vasisht, MD, PharmD
Kaveeta Vasisht MD, PharmD, is the Associate Commissioner for Women’s Health at the U.S. Food and Drug Administration (FDA). She directs the FDA Office of Women’s Health (OWH), which serves to protect and advance the health of women through scientific programs, policy development, research, education, stakeholder collaboration, and outreach.
Dr. Vasisht leads efforts to advance regulatory science through understanding sex differences, promoting the inclusion of women and diversity in clinical trials, and establishing women’s health research priorities at FDA. Under her leadership OWH recently developed the Knowledge and News on Women’s Health Initiative, bringing broader awareness to conditions that not only impact women, but also highlighting how health conditions can affect women differently. In addition, she leads efforts to bridge important knowledge gaps on medication use in pregnancy and lactation.
Dr. Vasisht and OWH have received numerous FDA awards in recognition of their contributions.
Prior to her current role, she served as a Deputy Director in FDA’s Center for Drug Evaluation and Research (CDER) Office of Medical Policy and has extensive expertise in leading regulatory policy development.
She also provided clinical expertise on multidisciplinary teams in the review and evaluation of scientific data to make regulatory decisions on the safety and effectiveness of therapeutics during her tenure in CDER’s Office of New Drugs.
Dr. Vasisht is board-certified in both internal medicine and adult endocrinology. She completed her internal medicine and endocrinology fellowship training at the University of Chicago Hospitals, where she also served on the faculty. She also holds a Doctor of Pharmacy degree from Rutgers College of Pharmacy where she graduated from the Honors Research Program.
Pauline M. Maki, PhD
Dr. Pauline M. Maki leads a National Institutes of Health (NIH) funded research program on women, cognition, mood, and dementia, with a particular focus on menopause. In her work, Dr. Maki utilizes multiple research methods, including clinical trials of hormonal and non-hormonal treatments for menopausal symptoms, cohort studies of the natural history of cognition and brain function across the menopausal transition, and neuroimaging studies. She also serves as Senior Director of Research at the University of Illinois Chicago Center for Research on Women and Gender.
Dr. Maki is Past President of the North American Menopause Society (NAMS), current Trustee of the International Menopause Society, Past Chair of the Society for Women’s Health Research Interdisciplinary Network on Alzheimer’s Disease, and Immediate Past Head of the Neurocognitive Working Group of the Women’s Interagency HIV Study.
Keli Walbert joined Horizon in 2018 and has more than 25 years of pharmaceutical and health care industry experience primarily focused on building integrated marketing teams and leading medicine launches. She previously led the U.S. commercial organization, overseeing the infused medicines portfolio, including the Horizon launches of TEPEZZA and UPLIZNA, life-cycle management and consumer and digital marketing. She currently leads Horizon’s strategic and corporate marketing.
Before joining Horizon, Walbert was with AbbVie where she led the consumer, advocacy and patient services functions as well as the overall launch of a drug-device combination product, DUOPA. Before AbbVie, she built and led the consumer organization at Abbott (now AbbVie) for the launch of HUMIRA. Walbert also held senior marketing and advertising leadership roles at the American Medical Association (AMA) and Draft Worldwide (now FCB), a global advertising agency.
Walbert has a bachelor’s degree in communication from the University of Louisville and a master’s degree in marketing communications from Northwestern University.
Julie Louise Gerberding, MD, MPH
Dr. Julie Louise Gerberding is the CEO of the Foundation for the National Institutes of Health, a non-profit organization that builds public-private research partnerships to support the mission of the NIH. She co-chairs the CSIS Commission on Strengthening America’s Health Security and is a member of the Commonwealth Fund Commission on a National Public Health System. Previously, she served as President of the vaccines business and as Executive Vice President and the Chief Patient Officer at Merck & Co., Inc. From 2003-2009, Dr. Gerberding led the U.S. Centers for Disease Control and Prevention (CDC). She serves on the boards of HilleVax, Mayo Clinic, National Health Council, and Case Western Reserve University. Dr. Gerberding is a member of the National Academy of Medicine and the adjunct faculties of the University of California, San Francisco, and Case Western Reserve University.
Meghan Feely, MD, FAAD
Meghan Feely, MD, FAAD is a Board Certified Dermatologist serving as an Executive Director at Eli Lilly & Company. Dr. Feely joined the company as a Senior Medical Advisor in Medical Affairs. She was subsequently named as an Indication Lead in Medical Affairs. Dr. Feely is a recipient of the Lilly Innovator Award and Immunology Team Lilly Town Hall Recognition. In her tenure at Eli Lilly, Dr. Feely has served as a Medical Affairs Lead for innovative real-world evidence data generation and as a dedicated advocate for advancing the scientific understanding of dermatologic disorders in Skin of Color patients. She is a strong proponent of community outreach and served as a Team Captain for the Lilly Global Day of Service.
Dr. Feely is a Fellow of the American Academy of Dermatology and Assistant Professor in Dermatology at Mount Sinai. She graduated summa cum laude from Dartmouth College as a Rhodes scholarship finalist and conducted research at the Immune Disease Institute at Harvard. She was thereafter awarded a merit-based scholarship to attend the Mayo Clinic College of Medicine, where she was recognized as Humanitarian of the Year. She completed her internship at a Tufts Medical Center affiliate and her Dermatology residency at Mount Sinai, serving as a Chief Resident.
Dr. Feely was a former contributor in the ABC News Medical Unit in New York City. She has sat on committees for the American Academy of Dermatology and the Women’s Dermatologic Society. Dr. Feely has been a recipient of NIH funding and authored numerous dermatologic disclosures. She has served as a session director and speaker at national dermatologic congresses. Dr. Feely utilizes her rich clinical and research experience to serve the needs of patients suffering from dermatologic disorders and to foster a steadfast commitment to scientific discovery and patient-centric innovation.
Sudip Parikh, PhD
Sudip Parikh is the CEO of the American Association for the Advancement of Science (AAAS) and executive publisher of the Science family of journals, since January 2020. Parikh has spent over two decades at the intersection of science, policy, and business as a Senate staffer, life science business leader, and in the policy community. He was awarded a National Science Foundation Graduate Research Fellowship while earning his Ph.D. in macromolecular structure and chemistry from the Scripps Research Institute in La Jolla, California and earned his BS in Applied Science from the University of North Carolina at Chapel Hill.
Gretta Stone is a health policy communications consultant at Reservoir Communications Group with deep knowledge of the biopharmaceutical sector and the health system more broadly.
At Reservoir, she works with a range of clients on advocacy, reputation, and organization brand. Before coming to Reservoir, she served as Deputy Vice President of Policy & Research at the Pharmaceutical Research and Manufacturers of America (PhRMA), where she led a range of issues related to the value of medicines, the R&D process, FDA regulation, and personalized medicine. In her more than 15 years at PhRMA, she worked extensively on orphan drugs, cancer, the biopharmaceutical pipeline, the research ecosystem, the cost of medicines, and marketing and promotion. Prior to joining PhRMA, Stone worked in a lab researching language and the brain at Georgetown University, where she received a Bachelor of Science in biology.
Florence Haseltine, PhD, MD
Academy of Managed Care Pharmacy
Alliance for Women’s Health and Prevention
American College of Obstetricians and Gynecologists
Medicaid Health Plans of America